Tuberculosis Research and Treatment / 2021 / Article / Tab 5

Research Article

Treatment Outcomes and Associated Factors in Tuberculosis Patients at Atwima Nwabiagya District, Ashanti Region, Ghana: A Ten-Year Retrospective Study

Table 5

Bivariate and multivariate analysis of factors associated with successful treatment.

VariableOR (95% CI) valueaOR (95% CI) value

Age (years)
(i) ≤205.57 (2.08-14.90)<0.0014.74 (1.75-12.83)0.002
(ii) 21-301.19 (0.74-1.90)0.4801.22 (0.74-2.00)0.428
(iii) 31-401.48 (0.95-2.30)0.0811.47 (0.92-2.35)0.103
(iv) 41-501.28 (0.82-1.99)0.2731.31 (0.83-2.07)0.251
(v) 51-602.06 (1.20-3.53)0.0091.94 (1.12-3.39)0.019
(vi) >60RefRef

Gender
(i) MaleRefRef
(ii) Female0.86 (0.64-1.17)0.3500.76 (0.55-1.06)0.111

Pretreatment weight (kg)
(i) ≤35RefRef
(ii) 36-452.54 (1.36-4.74)0.0042.54 (1.32-4.87)0.005
(iii) 46-552.50 (1.36-4.59)0.0032.75 (1.44-5.27)0.002
(iv) 56-652.79 (1.44-5.40)0.0023.04 (1.50-6.14)0.002
(v) >651.66 (0.75-3.65)0.2101.78 (0.78-4.04)0.170

HIV status
(i) NegativeRefRef
(ii) Positive0.69 (0.44-1.11)0.1270.68 (0.41-1.11)0.119

Disease classification
(i) Smear positive PTBRefRef
(ii) Smear negative PTB0.86 (0.51-1.47)0.5830.83 (0.48-1.45)0.518
(iii) Extra-PTB0.91 (0.55-1.50)0.7130.89 (0.53-1.50)0.668
(iv) MDR-TB

Patient category
(i) NewRefRef
(ii) Relapse0.63 (0.35-1.11)0.1100.60 (0.34-1.08)0.090
(iii) Transfer in3.13 (0.38-25.57)0.2873.00 (0.34-26.54)0.322
(iv) Failure2.24 (0.64-7.79)0.2071.90 (0.52-6.90)0.329
(v) Retreatment0.40 (0.16-1.00)0.0510.31 (0.11-0.84)0.021

Treatment support
(i) NoRefRef
(ii) Yes1.05 (0.66-1.68)0.8230.92 (0.56-1.51)0.740

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.